Artemis Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 24.89 Cr
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2018
- Satisfied Charges ₹ 121.00 Cr
- Revenue Growth 112.81%
- Profit Growth 7.27%
- Ebitda 17.79%
- Net Worth -0.45%
- Total Assets -0.15%
About Artemis Health Sciences
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33111DL2005PLC144156
-
Company No.
144156
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
28 Dec 2005
-
Date of AGM
03 Aug 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Artemis Health Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aastha Kalra
|
CFO | 04-May-2017 | Current |
|
Deepa Khatri
|
Company Secretary | 31-Oct-2017 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Ugar Anand
|
Director | 10-Nov-2017 | Current |
|
Shalini Chand
|
Director | 24-Jan-2007 | Current |
|
Onkar Kanwar
|
Director | 14-Sep-2006 | Current |
|
Anil Chopra
|
Director | 25-Feb-2015 | Current |
Financial Performance of Artemis Health Sciences.
Artemis Health Sciences Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 112.81% increase. The company also saw a slight improvement in profitability, with a 7.27% increase in profit. The company's net worth dipped by a decrease of 0.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Artemis Health Sciences?
In 2018, Artemis Health Sciences had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Artemis Medicare Services LimitedShalini Chand and Onkar Kanwar are mutual person
-
Ptl Enterprises LimitedOnkar Kanwar is a mutual person
-
Classic Industries And Exports LimitedOnkar Kanwar is a mutual person
-
Apollo Tyres Limited.Onkar Kanwar is a mutual person
-
Osk Consultants LlpOnkar Kanwar is a mutual person
-
O & T Consultants Llp
Onkar Kanwar is a mutual person
Charges (Loans)
₹0
₹121.00 Cr
Charges Breakdown by Lending Institutions
- State Bank Of Mysore : 64.00 Cr
- State Bank Of India : 57.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2014 | State Bank Of Mysore | ₹64.00 Cr | Satisfied |
| 03 Dec 2014 | State Bank Of India | ₹57.00 Cr | Satisfied |
How Many Employees Work at Artemis Health Sciences?
Unlock and access historical data on people associated with Artemis Health Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Artemis Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Artemis Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
